Brief: Nightingale Health H2 EBITDA Loss Narrows To EUR 5.1 Mln
Sept 20 (Reuters) - Nightingale Health Oyj HEALTH.HE :
* H2 REVENUE EUR 2.6 MILLION VERSUS EUR 1.9 MILLION YEAR
AGO
* H2 EBITDA LOSS EUR 5.1 MILLION VERSUS LOSS EUR 6.4
MILLION YEAR
AGO
* PROPOSES TO ANNUAL GENERAL MEETING THAT NO DIVIDEND BE
DISTRIBUTED FOR FINANCIAL YEAR 1 JULY 2023 - 30 JUNE 2024
Source text for Eikon: ID:nWkr4Mv3vH
Further company coverage: HEALTH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nightingale Health Oyj
See all newsBrief: Nightingale And The Private GP Group Enter Agreement
Brief: Siun Sote To Pilot Nightingale Health Risk Detection
Brief: Nightingale Enters Into Service Agreement In Latvia
Brief: Nightingale Health And Archipelago Health Sign Deal In Carribean, Bermuda
Finland's Nightingale Health annual revenue rises on expansion of commercial team